- Home
- OLED vs LNTH Comparison
OLED vs LNTH Comparison
Compare OLED & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLED | LNTH |
|---|---|---|
| Founded | 1985 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.4B |
| IPO Year | 1992 | 2015 |
Fundamental Metrics
Financial Performance| Metric | OLED | LNTH |
|---|---|---|
| Price | $117.73 | $66.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $181.33 | $78.00 |
| AVG Volume (30 Days) | 506.2K | ★ 1.1M |
| Earning Date | 02-19-2026 | 11-06-2025 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.64 | 2.39 |
| Revenue | $639,977,000.00 | ★ $1,525,933,000.00 |
| Revenue This Year | $2.50 | $0.01 |
| Revenue Next Year | $10.90 | $0.52 |
| P/E Ratio | ★ $25.64 | $28.07 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $103.70 | $47.25 |
| 52 Week High | $164.29 | $111.29 |
Technical Indicators
Market Signals| Indicator | OLED | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 43.40 | 64.70 |
| Support Level | $117.97 | $66.20 |
| Resistance Level | $120.32 | $67.45 |
| Average True Range (ATR) | 2.38 | 1.71 |
| MACD | 0.56 | -0.09 |
| Stochastic Oscillator | 44.60 | 74.36 |
Price Performance
Historical ComparisonAbout OLED Universal Display Corporation
Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.